Abstract

BackgroundZika virus (ZIKV) has been associated with several neurological complications in adult patients.MethodsWe used a mouse model deficient in TRIF and IPS-1 adaptor proteins, which are involved in type I interferon production, to study the role of microglia during brain infection by ZIKV. Young adult mice were infected intravenously with the contemporary ZIKV strain PRVABC59 (1 × 105 PFUs/100 µL).ResultsInfected mice did not present overt clinical signs of the disease nor body weight loss compared with noninfected animals. However, mice exhibited a viremia and a brain viral load that were maximal (1.3 × 105 genome copies/mL and 9.8 × 107 genome copies/g of brain) on days 3 and 7 post-infection (p.i.), respectively. Immunohistochemistry analysis showed that ZIKV antigens were distributed in several regions of the brain, especially the dorsal hippocampus. The number of Iba1+/TMEM119+ microglia remained similar in infected versus noninfected mice, but their cell body and arborization areas significantly increased in the stratum radiatum and stratum lacunosum-moleculare layers of the dorsal hippocampus cornu ammoni (CA)1, indicating a reactive state. Ultrastructural analyses also revealed that microglia displayed increased phagocytic activities and extracellular digestion of degraded elements during infection. Mice pharmacologically depleted in microglia with PLX5622 presented a higher brain viral load compared to untreated group (2.8 × 1010versus 8.5 × 108 genome copies/g of brain on day 10 p.i.) as well as an increased number of ZIKV antigens labeled with immunogold in the cytoplasm and endoplasmic reticulum of neurons and astrocytes indicating an enhanced viral replication. Furthermore, endosomes of astrocytes contained nanogold particles together with digested materials, suggesting a compensatory phagocytic activity upon microglial depletion.ConclusionsThese results indicate that microglia are involved in the control of ZIKV replication and/or its elimination in the brain. After depletion of microglia, the removal of ZIKV-infected cells by phagocytosis could be partly compensated by astrocytes.

Highlights

  • Zika virus (ZIKV) has been associated with several neurological complications in adult patients

  • The removal of ZIKV-infected cells by phagocytosis could be partly compensated by astrocytes

  • ZIKV is associated with a viremia and a brain viral load without causing mortality Young adult ­Toll-interleukin-1 receptor domain-containing adaptor inducing IFN-β (TRIF)−/−xIPS-1−/− mice infected intravenously with 1 × ­105 Plaque-forming units (PFU) of ZIKV strain PRVABC59 did not exhibit clinical signs of the disease, and all mice survived after infection

Read more

Summary

Introduction

Zika virus (ZIKV) has been associated with several neurological complications in adult patients. ZIKV RNA has been detected by RT-PCR in the CSF and brain of adult patients presenting with neurological disorders [10, 11]. Magnetic resonance imaging showed brain abnormalities similar to those caused by other flaviviruses such as West Nile virus and Japanese encephalitis virus, but no specific findings could be associated with ZIKV [14]. These data suggest that ZIKV can invade the central nervous system (CNS) of adult individuals and promote neuroinflammation. The mechanisms underlying neurological disorders induced by ZIKV in the mature brain have not been completely elucidated

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call